(Q45419445)

14 December 2017

CXCR₄antagonism as a therapeutic approach to prevent acute kidney injury (English)

1 reference

14 December 2017

A Zuk

1

1 reference

14 December 2017

M Gershenovich

2

1 reference

14 December 2017

Y Ivanova

3

1 reference

14 December 2017

R T MacFarland

4

1 reference

14 December 2017

S P Fricker

5

1 reference

14 December 2017

S Ledbetter

6

1 reference

14 December 2017

30 July 2014

1 reference

American Journal of Physiology - Renal Physiology

14 December 2017

1 reference

14 December 2017

307

1 reference

14 December 2017

7

1 reference

14 December 2017

F783-97

1 reference

The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

14 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Angiostatin and matrix metalloprotease expression following ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Ischemic acute renal failure: an inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Survival and distribution of injected haematopoietic stem cells in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Tubular leakage and obstruction after renal ischemia: structural-functional correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Macrophages and immunologic inflammation of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Haematopoietic lineage-committed bone marrow cells, but not cloned cultured mesenchymal stem cells, contribute to regeneration of renal tubular epithelium after HgCl 2 -induced acute tubular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Acute kidney injury increases risk of ESRD among elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Inflammation in acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Postischemic renal injury is mediated by neutrophils and leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

SDF-1 activates papillary label-retaining cells during kidney repair from injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1/CXCR4-axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Imperfect gold standards for kidney injury biomarker evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

Expression of fibronectin splice variants in the postischemic rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00685.2013

10.1152/AJPRENAL.00685.2013

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference